Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Total Liabilities
Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has total liabilities worth CN¥1.62 Billion CNY (≈ $236.76 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how many days can Guizhou Xinbang Pharmaceutical Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Guizhou Xinbang Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 002390 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Suzhou Shihua New Material Technology Co Ltd
SHG:688093
|
China | CN¥119.49 Million |
|
Ningxia Building Materials Group Co Ltd
SHG:600449
|
China | CN¥1.60 Billion |
|
Shanghai Haohai Biological Tech Co
SHG:688366
|
China | CN¥1.23 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥514.94 Million |
|
Blacksky Technology Inc
NYSE:BKSY
|
USA | $305.49 Million |
|
Danya Cebus
TA:DNYA
|
Israel | ILA2.55 Billion |
|
Lithium Argentina AG
NYSE:LAR
|
USA | $251.73 Million |
|
Bear Electric Appliance Co Ltd
SHE:002959
|
China | CN¥2.52 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Guizhou Xinbang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Guizhou Xinbang Pharmaceutical Co Ltd's balance sheet.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guizhou Xinbang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.01 Billion ≈ $293.89 Million |
-4.49% |
| 2023-12-31 | CN¥2.10 Billion ≈ $307.72 Million |
-22.92% |
| 2022-12-31 | CN¥2.73 Billion ≈ $399.20 Million |
-2.57% |
| 2021-12-31 | CN¥2.80 Billion ≈ $409.75 Million |
-37.69% |
| 2020-12-31 | CN¥4.49 Billion ≈ $657.57 Million |
-16.34% |
| 2019-12-31 | CN¥5.37 Billion ≈ $785.96 Million |
-5.54% |
| 2018-12-31 | CN¥5.69 Billion ≈ $832.01 Million |
+9.42% |
| 2017-12-31 | CN¥5.20 Billion ≈ $760.38 Million |
+20.51% |
| 2016-12-31 | CN¥4.31 Billion ≈ $630.99 Million |
+12.41% |
| 2015-12-31 | CN¥3.84 Billion ≈ $561.31 Million |
+38.71% |
| 2014-12-31 | CN¥2.77 Billion ≈ $404.66 Million |
+513.59% |
| 2013-12-31 | CN¥450.69 Million ≈ $65.95 Million |
+44.46% |
| 2012-12-31 | CN¥311.99 Million ≈ $45.65 Million |
+18.17% |
| 2011-12-31 | CN¥264.02 Million ≈ $38.63 Million |
+59.23% |
| 2010-12-31 | CN¥165.81 Million ≈ $24.26 Million |
-23.77% |
| 2009-12-31 | CN¥217.51 Million ≈ $31.83 Million |
-7.46% |
| 2008-12-31 | CN¥235.04 Million ≈ $34.39 Million |
+8.32% |
| 2007-12-31 | CN¥216.99 Million ≈ $31.75 Million |
-7.73% |
| 2006-12-31 | CN¥235.18 Million ≈ $34.41 Million |
-- |
About Guizhou Xinbang Pharmaceutical Co Ltd
Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological m… Read more